TLT News 111.02 06/11/2014 05:27:43 20+ Year Trsy Bond Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
20+ Year Trsy Bond Ishares (TLT) 111.02 $TLT

ETF Asset Flow Roundup: Emerging Bond Gains, U.S. Bond Suffers - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Jun 09, 1:00PM CDT
Which ETFs saw the biggest inflows and outflows from last week?

Notable ETF Outflow Detected - TLT
ETFChannel.com - Thu Jun 05, 9:56AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 20+ Year Treasury Bond ETF where we have detected an approximate $55.7 million dollar outflow -- that's a 1.4%...

Which Will Fail First, Treasury Bonds or Transportation Stocks?
at The Street - Wed Jun 04, 1:52PM CDT
Both Treasury bonds and transportation stocks are rallying simultaneously. Will one sector fail?

iShares Barclays 20+ Year Treasury Bond Fund Falls 1.23% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 03, 3:39PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $111.51 to a high of $112.54. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $112.55 on volume of 12.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.23%, iShares Barclays 20+ Year Treasury Bond Fund Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jun 03, 3:38PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $111.51 to a high of $112.54. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $112.55 on volume of 12.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iShares Barclays 20+ Year Treasury Bond Fund to Potentially Rebound After Falling 1.23% Yesterday
Comtex SmarTrend(R) - Tue Jun 03, 3:38PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $111.51 to a high of $112.54. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $112.55 on volume of 12.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look Abroad When You Have an American Trendless Market
at The Street - Tue Jun 03, 1:11PM CDT
You can't judge this market by the headlines. But India is showing much greater potential.

Blind Bulls, Tortured Bears, and the ISM Oops - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon Jun 02, 3:06PM CDT
Remind me again, why do we "need" a correction?

The Money-Manager Feud of the Year
at The Street - Mon Jun 02, 8:40AM CDT
This week equity and bond investors will learn which group is on the right path, after prices have been pushed higher for most of the year.

Weaker Economic Data Set Up a June Swoon for Stocks and Bonds
at The Street - Fri May 30, 9:46AM CDT
Consider taking profits in exchange-traded funds that track major markets, such as the SPDR Dow 30 ETF, the SPDR S&P 500 and the PowerShares QQQ.

'Fast Money' Recap: Music to the Market's Ears?
at The Street - Thu May 29, 4:00AM CDT
The trading panel looks at Apple's purchase of Beats Electronics.

Look for Shares of iShares Barclays 20+ Year Treasury Bond Fund to Potentially Pullback after Yesterday's 1.24% Rise
Comtex SmarTrend(R) - Wed May 28, 3:40PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.09 to a high of $114.84. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $113.40 on volume of 9.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.24% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed May 28, 3:40PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.09 to a high of $114.84. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $113.40 on volume of 9.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of iShares Barclays 20+ Year Treasury Bond Fund After 1.24% Gain
Comtex SmarTrend(R) - Wed May 28, 3:39PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.09 to a high of $114.84. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $113.40 on volume of 9.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Remembrance and a Thank You. $ES_F 1894 x 1882
Marlin Cobb - at MTS - Fri May 23, 9:56AM CDT
Featured Breadth Chart of the Day Pushing the 90s. Not good for the bears, it really needs to fall apart soon. Quote of the Day:Injustice is relatively easy to bear; what stings is justice.–H.L. Mencken Comments and Levels for the Front...

It is a waiting game, like being a vet: $ES_f 1892 x 1855
Marlin Cobb - at MTS - Thu May 22, 8:51AM CDT
  Featured Breadth Chart of the Day Ping pong on the A/D lines as we bounce up, but the bulls have shown a two-fer in here.  Two days of up and get those numbers back up. Quote of the Day:I was so hungry I could have eaten a horse. But only...

'Fast Money' Recap: Going Global
at The Street - Thu May 22, 4:00AM CDT
The trading panel provided their international picks and whether Netflix can make it in Europe.

Double Rainbow, what does it mean? $ES_F 1891 x 1862
Marlin Cobb - at MTS - Wed May 21, 10:00AM CDT
Featured Breadth Chart of the Day That 90′s scare is over, but we should be dropping like a rock here.  This delayed reaction should be a bit worrisome for us bears. Quote of the Day:The easiest thing to find is fault.–Anonymous...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 273

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 79

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 189

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 188

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring AI's Impact on CRM Visibility and Brand Trust

Updated Category News Views 217

Understanding the Role of AI in CRM Visibility Brandi AI has recently launched its AI Visibility Index series, which offers insightful measurements of how industries are perceived in AI-generated responses. This new series highlights the ways in which customer relationship management (CRM) brands are represented through the lens of advanced AI answer engines. The AI...

Continue Reading
Celldex Therapeutics Thrives Amid Developments with Briquilimab

Updated Category News Views 148

Overview of Celldex Therapeutics and Briquilimab Celldex Therapeutics (NASDAQ: CLDX) is navigating an exciting phase as it explores treatments for chronic conditions like Chronic Inducible Urticaria (CIndU). Analysts have closely observed the efficacy of briquilimab, highlighting its performance through recent studies. Analyst Insights on Celldex and Briquilimab Goldman...

Continue Reading
XPENG's Financial Success in Q3 2024: Key Insights Revealed

Updated Category News Views 238

XPENG's Journey in the Third Quarter of 2024 XPeng Inc. (“XPENG” or “the Company,” NYSE: XPEV and HKEX: 9868) recently disclosed its financial results for the third quarter ended September 30, 2024. This marks a significant period showcasing growth in revenues and vehicle deliveries, reflecting the company's robust strategy in the smart electric vehicle market....

Continue Reading
Apple Inc. Beats Earnings Expectations: Analysts React

Updated Category News Views 144

Apple Inc. Overcomes Challenges with Strong Quarterly Results Apple Inc.‘s latest quarterly performance has generated significant buzz in the tech world. Analysts reveal that the results showcase a resilient company navigating through various market challenges. This performance not only reflects strong sales of products like the iPhone but also highlights impressive...

Continue Reading
Class Action Alert: Investors Have Rights with AMMO, Inc.

Updated Category News Views 237

Class Action Lawsuit Against AMMO, Inc. In a proactive move for investors, Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against AMMO, Inc. (NASDAQ: POWW). This suit comes in light of significant losses experienced by investors in the company due to alleged misstatements and omissions regarding its business practices. Understanding the Class...

Continue Reading